Homozygous and hemizygous DOCK11 deficiency has also been newly associated with hyper-inflammatory states [68,69], but whether DOCK11 mutations contribute to CSS or severe COVID-19 is currently unknown. This evidence concerns the gene DOCK11 and COVID-19.